HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Richard Greil Selected Research

(23R,24S)- 16,23- 16,24- diepoxy- 9,19- cyclolanostan- 3beta,15alpha,25- triol

2/2020Structure-Guided Identification of Black Cohosh (Actaea racemosa) Triterpenoids with In Vitro Activity against Multiple Myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Richard Greil Research Topics

Disease

113Neoplasms (Cancer)
02/2022 - 01/2002
85Breast Neoplasms (Breast Cancer)
05/2022 - 01/2004
35Colorectal Neoplasms (Colorectal Cancer)
11/2021 - 01/2007
27B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2022 - 01/2002
21Multiple Myeloma
02/2020 - 03/2004
19Disease Progression
01/2022 - 02/2009
18Hodgkin Disease (Hodgkin's Disease)
06/2021 - 01/2002
14Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2022 - 07/2015
13Neoplasm Metastasis (Metastasis)
11/2021 - 04/2005
12Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 01/2014
11Neutropenia
01/2020 - 07/2009
10Lymphoma (Lymphomas)
01/2022 - 04/2005
10Infections
01/2020 - 01/2002
9Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2022 - 12/2013
6Squamous Cell Carcinoma of Head and Neck
01/2022 - 01/2013
6Residual Neoplasm
01/2022 - 06/2009
6Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2022 - 03/2010
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2021 - 03/2018
6Hemorrhage
12/2020 - 02/2012
6Fatigue
05/2020 - 12/2010
6Diarrhea
01/2020 - 12/2011
5Myelodysplastic Syndromes (Myelodysplastic Syndrome)
05/2022 - 12/2013
5Triple Negative Breast Neoplasms
01/2022 - 10/2013
5Hypertension (High Blood Pressure)
01/2022 - 02/2013
5Head and Neck Neoplasms (Head and Neck Cancer)
11/2021 - 01/2013
5Hematologic Neoplasms (Hematological Malignancy)
08/2021 - 09/2014
5Anemia
05/2021 - 04/2008
5Adenocarcinoma
04/2021 - 01/2019
5Pathologic Complete Response
01/2021 - 05/2007
5Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2020 - 04/2005
5Stomach Neoplasms (Stomach Cancer)
03/2020 - 03/2008
4B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 02/2015
4Peripheral Nervous System Diseases (PNS Diseases)
09/2021 - 02/2013

Drug/Important Bio-Agent (IBA)

25Hormones (Hormone)IBA
02/2022 - 08/2005
22Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2022 - 01/2002
20Doxorubicin (Adriamycin)FDA LinkGeneric
02/2022 - 01/2002
19Rituximab (Mabthera)FDA Link
02/2022 - 09/2006
18Fluorouracil (Carac)FDA LinkGeneric
01/2021 - 09/2007
17Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2009
15Bevacizumab (Avastin)FDA Link
06/2020 - 06/2011
14Vincristine (Oncovin)FDA LinkGeneric
02/2022 - 01/2002
14Capecitabine (Xeloda)FDA Link
01/2021 - 09/2007
12Prednisone (Sone)FDA LinkGeneric
02/2022 - 01/2002
12Cetuximab (Erbitux)FDA Link
01/2022 - 12/2011
12Lenalidomide (CC 5013)FDA Link
01/2022 - 03/2014
12Bleomycin (Blenoxane)FDA LinkGeneric
06/2021 - 01/2002
12TamoxifenFDA LinkGeneric
11/2020 - 08/2005
12Dexamethasone (Maxidex)FDA LinkGeneric
01/2020 - 04/2009
11Pharmaceutical PreparationsIBA
11/2021 - 08/2002
11Trastuzumab (Herceptin)FDA Link
03/2020 - 02/2009
10Aromatase InhibitorsIBA
05/2022 - 12/2007
10human ERBB2 proteinIBA
02/2022 - 03/2012
10Immune Checkpoint InhibitorsIBA
01/2022 - 01/2016
10Estrogen ReceptorsIBA
11/2021 - 06/2009
10Docetaxel (Taxotere)FDA Link
01/2021 - 05/2007
10Anastrozole (Arimidex)FDA LinkGeneric
01/2021 - 08/2005
8Azacitidine (5 Azacytidine)FDA Link
05/2022 - 08/2011
8Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2021 - 09/2007
8Zoledronic Acid (Zometa)FDA Link
04/2020 - 09/2008
7GemcitabineFDA Link
01/2022 - 01/2020
7MicroRNAs (MicroRNA)IBA
01/2021 - 07/2010
7LigandsIBA
01/2020 - 09/2003
6DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2015
6Monoclonal AntibodiesIBA
01/2022 - 09/2012
6Cisplatin (Platino)FDA LinkGeneric
11/2021 - 01/2013
6ParaffinIBA
11/2021 - 09/2011
6Formaldehyde (Formol)FDA Link
11/2021 - 09/2011
6AntigensIBA
10/2021 - 04/2009
6Procarbazine (Matulane)FDA Link
06/2021 - 01/2002
6Etoposide (VP 16)FDA LinkGeneric
06/2021 - 01/2002
6Irinotecan (Camptosar)FDA LinkGeneric
04/2021 - 07/2009
6Dacarbazine (DIC)FDA LinkGeneric
04/2021 - 01/2002
6Vinblastine (Vinblastine Sulfate)FDA Link
04/2021 - 01/2002
6Thalidomide (Thalomid)FDA Link
01/2020 - 04/2009
6Bortezomib (Velcade)FDA Link
09/2019 - 10/2010
5pembrolizumabIBA
01/2022 - 12/2018
5ErbB Receptors (EGF Receptor)IBA
01/2022 - 10/2013
5folfirinoxIBA
01/2022 - 01/2014
5Leucovorin (Folinic Acid)FDA Link
01/2021 - 09/2007
5Proteins (Proteins, Gene)FDA Link
01/2021 - 06/2014
5Integrin alpha4beta1 (VLA-4)IBA
01/2021 - 04/2009
5Goserelin (Zoladex)FDA Link
11/2020 - 09/2008
5Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2020 - 05/2007
5ChemokinesIBA
11/2016 - 04/2005
4Chlorambucil (Leukeran)FDA Link
01/2022 - 01/2019
4Antineoplastic Agents (Antineoplastics)IBA
01/2022 - 08/2002
4ibrutinibIBA
01/2022 - 01/2019
4obinutuzumabIBA
01/2022 - 01/2019
4Chimeric Antigen ReceptorsIBA
01/2022 - 04/2020
4Bendamustine HydrochlorideFDA Link
01/2022 - 02/2014
4L-BLP25IBA
01/2021 - 04/2012

Therapy/Procedure

128Therapeutics
05/2022 - 01/2002
64Drug Therapy (Chemotherapy)
05/2022 - 04/2005
19Radiotherapy
11/2021 - 01/2002
12Neoadjuvant Therapy
08/2020 - 03/2007
9Adjuvant Chemotherapy
02/2022 - 03/2012
5Chemoradiotherapy
11/2021 - 03/2014
5Aftercare (After-Treatment)
05/2021 - 08/2002
5Induction Chemotherapy
01/2021 - 01/2013
5Immunotherapy
01/2020 - 04/2012